ReP USP - Resultado da busca

Artigo de periodico
Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns (2022)
Messiano, Claudia Garcia; Morales Júnior, Ronaldo ; Pereira, Gabriela Otofuji; Silva Junior, Elson Mendes da; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Clinical Therapeutics. Unidades: FCF, FM
Subjects: QUEIMADURAS, FARMACODINÂMICA, FARMACOCINÉTICA, SEPSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MESSIANO, Claudia Garcia et al. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, v. 44, p. 624-629, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2022.02.007. Acesso em: 17 nov. 2024.
APA
Messiano, C. G., Morales Júnior, R., Pereira, G. O., Silva Junior, E. M. da, Gomez, D. de S., & Santos, S. R. C. J. (2022). Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, 44, 624-629. doi:10.1016/j.clinthera.2022.02.007
NLM
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007
Vancouver
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007
Artigo de periodico
PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock (2021)
Camargo, Thais Vieira de; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Santos, Verônica Jorge; Rocha, Adriana; Lanchote, Vera Lucia ; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Brazilian Journal of Health Review. Unidades: FM, FCFRP, FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA, CHOQUE SÉPTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Thais Vieira de et al. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock. Brazilian Journal of Health Review, v. 4, n. 1, p. 1213-1232, 2021Tradução . . Disponível em: https://doi.org/10.34119/bjhrv4n1-107. Acesso em: 17 nov. 2024.
APA
Camargo, T. V. de, Silva Júnior, J. M. da, Silva Junior, E. M. da, Santos, V. J., Rocha, A., Lanchote, V. L., et al. (2021). PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock. Brazilian Journal of Health Review, 4( 1), 1213-1232. doi:10.34119/bjhrv4n1-107
NLM
Camargo TV de, Silva Júnior JM da, Silva Junior EM da, Santos VJ, Rocha A, Lanchote VL, Santos SRCJ, Gomez D de S. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock [Internet]. Brazilian Journal of Health Review. 2021 ; 4( 1): 1213-1232.[citado 2024 nov. 17 ] Available from: https://doi.org/10.34119/bjhrv4n1-107
Vancouver
Camargo TV de, Silva Júnior JM da, Silva Junior EM da, Santos VJ, Rocha A, Lanchote VL, Santos SRCJ, Gomez D de S. PK/PD approach to evaluate Meropenem effectiveness in critically ill burn adolescents versus young adults undergoing therapy of septic shock [Internet]. Brazilian Journal of Health Review. 2021 ; 4( 1): 1213-1232.[citado 2024 nov. 17 ] Available from: https://doi.org/10.34119/bjhrv4n1-107
Trabalho de evento-resumo periodico
Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains (2019)
Kupa, Leonard de Vinci Kanda; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Oliveira, Amanda Maria Ribas Rosa de; Gomides, Aline Sandre; Silva, Cristina Carvalho da; Ferreira, Gabriela Aparecida; Oliveira, Thiago Camara; Duarte, Nilo José Coelho; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: UNIDADES DE TERAPIA INTENSIVA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 17 nov. 2024. , 2019
APA
Kupa, L. de V. K., Silva Júnior, J. M. da, Silva Junior, E. M. da, Oliveira, A. M. R. R. de, Gomides, A. S., Silva, C. C. da, et al. (2019). Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains [Internet]. Critical Care. 2019 ; 23 res.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains [Internet]. Critical Care. 2019 ; 23 res.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients (2019)
Souza, Vanessa Kasubeck de; Silva Junior, Elson Mendes da; Matsuno, Victor Kaneko; Gomides, Aline Sandre; Silva Júnior, João Manoel da; Oliveira, Thiago Camara; Ferreira, Gabriela Aparecida; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: BACTÉRIAS GRAM-NEGATIVAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Vanessa Kasubeck de et al. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 17 nov. 2024. , 2019
APA
Souza, V. K. de, Silva Junior, E. M. da, Matsuno, V. K., Gomides, A. S., Silva Júnior, J. M. da, Oliveira, T. C., et al. (2019). Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Souza VK de, Silva Junior EM da, Matsuno VK, Gomides AS, Silva Júnior JM da, Oliveira TC, Ferreira GA, Gomez D de S, Santos SRCJ. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients [Internet]. Critical Care. 2019 ; 23 20-21 res. P35.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Souza VK de, Silva Junior EM da, Matsuno VK, Gomides AS, Silva Júnior JM da, Oliveira TC, Ferreira GA, Gomez D de S, Santos SRCJ. Extended two-hour infusion improves piperacillin effectiveness against susceptible strains in septic burn patients [Internet]. Critical Care. 2019 ; 23 20-21 res. P35.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock (2019)
Kupa, Leonard de Vinci Kanda; Silva Júnior, João Manoel da; Silva Junior, Elson Mendes da; Oliveira, Amanda Maria Ribas Rosa de; Gomides, Aline Sandre; Silva, Cristina Carvalho da; Ferreira, Gabriela Aparecida; Oliveira, Thiago Camara; Duarte, Nilo José Coelho; Gomez, David de Souza; Guillaux, Camila Salinas; Santos, Silvia Regina Cavani Jorge
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: SEPSE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 17 nov. 2024. , 2019
APA
Kupa, L. de V. K., Silva Júnior, J. M. da, Silva Junior, E. M. da, Oliveira, A. M. R. R. de, Gomides, A. S., Silva, C. C. da, et al. (2019). Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Kupa L de VK, Silva Júnior JM da, Silva Junior EM da, Oliveira AMRR de, Gomides AS, Silva CC da, Ferreira GA, Oliveira TC, Duarte NJC, Gomez D de S, Guillaux CS, Santos SRCJ. Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock [Internet]. Critical Care. 2019 ; 23 17 res. P31.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l (2019)
Pires, Frederico Ribeiro; Delgado, Artur Figueiredo ; Campos, Edvaldo Vieira de; Silva, Cristina Carvalho da; Fedeli, Juliana Gadelha; Duarte, Nilo José Coelho; Kupa, Leonard de Vinci Kanda; Matsuno, Victor Kaneko; Messiano, Claudia Garcia; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FCF, FM
Subjects: FARMACOCINÉTICA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Frederico Ribeiro et al. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 17 nov. 2024. , 2019
APA
Pires, F. R., Delgado, A. F., Campos, E. V. de, Silva, C. C. da, Fedeli, J. G., Duarte, N. J. C., et al. (2019). Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l. Critical Care. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Pires FR, Delgado AF, Campos EV de, Silva CC da, Fedeli JG, Duarte NJC, Kupa L de VK, Matsuno VK, Messiano CG, Santos SRCJ, Gomez D de S. Vancomycin effectiveness in critically septic pediatric burn patients compared with nonburn patients requires dose adjustment for target attainment against Staphylococcus spp. MIC 1 mg/l [Internet]. Critical Care. 2019 ; 23 19-20 res. P34.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus (2019)
Campos, Edvaldo Vieira de; Kupa, Leonard de Vinci Kanda; Macedo, Vedilaine Aparecida Bueno da Silva; Camargo, Thais Vieira de; Silva Júnior, João Manoel da; Silva, Cristina Carvalho da; Pereira Junior, José Gomes; Fedeli, Juliana Gadelha; Duarte, Nilo José Coelho; Santos, Silvia Regina Cavani Jorge ; Gomez, David de Souza
Source: Critical Care. Conference titles: International Symposium on Intensive Care and Emergency Medicine for Latin America. Unidades: FM, FCF
Subjects: FARMACOCINÉTICA, STAPHYLOCOCCUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Edvaldo Vieira de et al. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13054-019-2503-9. Acesso em: 17 nov. 2024. , 2019
APA
Campos, E. V. de, Kupa, L. de V. K., Macedo, V. A. B. da S., Camargo, T. V. de, Silva Júnior, J. M. da, Silva, C. C. da, et al. (2019). The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus. Critical Care. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13054-019-2503-9
NLM
Campos EV de, Kupa L de VK, Macedo VAB da S, Camargo TV de, Silva Júnior JM da, Silva CC da, Pereira Junior JG, Fedeli JG, Duarte NJC, Santos SRCJ, Gomez D de S. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus [Internet]. Critical Care. 2019 ; 23 19 res. P33.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Vancouver
Campos EV de, Kupa L de VK, Macedo VAB da S, Camargo TV de, Silva Júnior JM da, Silva CC da, Pereira Junior JG, Fedeli JG, Duarte NJC, Santos SRCJ, Gomez D de S. The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus [Internet]. Critical Care. 2019 ; 23 19 res. P33.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1186/s13054-019-2503-9
Trabalho de evento-resumo periodico
Meropenem in paediatric critically ill patient under renal replacement therapy (2018)
Kupa, Léonard de Vinci Kanda; Gomez, David de Souza; Silva Junior, Elson Mendes da; Silva Júnior, João Manoel da; Duarte, Nilo José Coelho; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: CHOQUE SÉPTICO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Léonard de Vinci Kanda et al. Meropenem in paediatric critically ill patient under renal replacement therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2018
APA
Kupa, L. de V. K., Gomez, D. de S., Silva Junior, E. M. da, Silva Júnior, J. M. da, Duarte, N. J. C., & Santos, S. R. C. J. (2018). Meropenem in paediatric critically ill patient under renal replacement therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Kupa L de VK, Gomez D de S, Silva Junior EM da, Silva Júnior JM da, Duarte NJC, Santos SRCJ. Meropenem in paediatric critically ill patient under renal replacement therapy. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 28 res. FCF052.[citado 2024 nov. 17 ]
Vancouver
Kupa L de VK, Gomez D de S, Silva Junior EM da, Silva Júnior JM da, Duarte NJC, Santos SRCJ. Meropenem in paediatric critically ill patient under renal replacement therapy. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 28 res. FCF052.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Meropenem-vancomycin to treat septic paediatric critically ill patient (2018)
Camargo, Thais Vieira de; Santos, Silvia Regina Cavani Jorge ; Balzi, Ana Paula de Carvalho Canela; Malbouisson, Luiz Marcelo; Gomez, David de Souza; Duarte, Nilo José Coelho
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: CHOQUE SÉPTICO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Thais Vieira de et al. Meropenem-vancomycin to treat septic paediatric critically ill patient. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2018
APA
Camargo, T. V. de, Santos, S. R. C. J., Balzi, A. P. de C. C., Malbouisson, L. M., Gomez, D. de S., & Duarte, N. J. C. (2018). Meropenem-vancomycin to treat septic paediatric critically ill patient. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Camargo TV de, Santos SRCJ, Balzi AP de CC, Malbouisson LM, Gomez D de S, Duarte NJC. Meropenem-vancomycin to treat septic paediatric critically ill patient. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 30 res. FCF055.[citado 2024 nov. 17 ]
Vancouver
Camargo TV de, Santos SRCJ, Balzi AP de CC, Malbouisson LM, Gomez D de S, Duarte NJC. Meropenem-vancomycin to treat septic paediatric critically ill patient. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 30 res. FCF055.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass (2017)
Silva Filho, Carlos Roberto da; Barbosa, Ricardo Antonio Guimarães; Silva Junior, Carlindo Vieira da; Carmona, Maria José Carvalho; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidades: FCF, FM
Subjects: CIRURGIA TORÁCICA, FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA FILHO, Carlos Roberto da et al. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2017
APA
Silva Filho, C. R. da, Barbosa, R. A. G., Silva Junior, C. V. da, Carmona, M. J. C., Gomez, D. de S., & Santos, S. R. C. J. (2017). Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva Filho CR da, Barbosa RAG, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 80 res. CFSP142.[citado 2024 nov. 17 ]
Vancouver
Silva Filho CR da, Barbosa RAG, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Pharmacokinetic-pharmacodynamic approach of unbound plasma propofol during coronary surgery with and without cardiopulmonary bypass. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 80 res. CFSP142.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome (2017)
Silva Filho, Carlos Roberto da; Silva Junior, Carlindo Vieira da; Carmona, Maria José Carvalho; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidades: FCF, FM
Assunto: FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA FILHO, Carlos Roberto da et al. Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2017
APA
Silva Filho, C. R. da, Silva Junior, C. V. da, Carmona, M. J. C., Gomez, D. de S., & Santos, S. R. C. J. (2017). Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva Filho CR da, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 55 res. FCF105.[citado 2024 nov. 17 ]
Vancouver
Silva Filho CR da, Silva Junior CV da, Carmona MJC, Gomez D de S, Santos SRCJ. Application of the two-compartment model to evaluate the pharmacokinetics of unbound plasma propofol during coronary surgery with hypothermic cardiopulmonary bypass with consequences on desired outcome. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 55 res. FCF105.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic (2017)
Macedo, Vedilaine Aparecida Bueno da Silva; Silva Júnior, João Manoel da; Campos, Edvaldo Vieira; Silva Junior, Carlindo Vieira da; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: CHOQUE SÉPTICO, STAPHYLOCOCCUS, FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Vedilaine Aparecida Bueno da Silva et al. Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2017
APA
Macedo, V. A. B. da S., Silva Júnior, J. M. da, Campos, E. V., Silva Junior, C. V. da, Gomez, D. de S., & Santos, S. R. C. J. (2017). Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Macedo VAB da S, Silva Júnior JM da, Campos EV, Silva Junior CV da, Gomez D de S, Santos SRCJ. Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 33 res. FCF062.[citado 2024 nov. 17 ]
Vancouver
Macedo VAB da S, Silva Júnior JM da, Campos EV, Silva Junior CV da, Gomez D de S, Santos SRCJ. Vancomycin daily dose recommended to pediatric septic burn patients against staphylococcus spp. and effectiveness based on ratio area under the curve and mic. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 33 res. FCF062.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics? (2017)
Silva, Vedilaine Aparecida Bueno da; Silva Júnior, João Manoel da; Campos, Edvaldo Vieira de; Silva Junior, Carlindo Vieira da; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: STAPHYLOCOCCUS, FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vedilaine Aparecida Bueno da et al. Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics?. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2017
APA
Silva, V. A. B. da, Silva Júnior, J. M. da, Campos, E. V. de, Silva Junior, C. V. da, Gomez, D. de S., & Santos, S. R. C. J. (2017). Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics? Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva VAB da, Silva Júnior JM da, Campos EV de, Silva Junior CV da, Gomez D de S, Santos SRCJ. Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 113 res. CFSP209.[citado 2024 nov. 17 ]
Vancouver
Silva VAB da, Silva Júnior JM da, Campos EV de, Silva Junior CV da, Gomez D de S, Santos SRCJ. Is vancomycin therapeutic target against Staphylococcus SPP MIC1mg/L achieved after the empirical dose regimen recommended to critically septic pediatrics? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 113 res. CFSP209.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
PK/PD aproach for imipenem target attainment against agressive strains mic 4 MG/L in septic burns (2016)
Kupa, Leonard de Vinci Kanda; Silva-Jr, Carlindo Vieira; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: QUEIMADURAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUPA, Leonard de Vinci Kanda et al. PK/PD aproach for imipenem target attainment against agressive strains mic 4 MG/L in septic burns. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2016
APA
Kupa, L. de V. K., Silva-Jr, C. V., Gomez, D. de S., & Santos, S. R. C. J. (2016). PK/PD aproach for imipenem target attainment against agressive strains mic 4 MG/L in septic burns. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Kupa L de VK, Silva-Jr CV, Gomez D de S, Santos SRCJ. PK/PD aproach for imipenem target attainment against agressive strains mic 4 MG/L in septic burns. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 11 res. FCF004.[citado 2024 nov. 17 ]
Vancouver
Kupa L de VK, Silva-Jr CV, Gomez D de S, Santos SRCJ. PK/PD aproach for imipenem target attainment against agressive strains mic 4 MG/L in septic burns. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 11 res. FCF004.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Vancomycin dose adjustment in pediatric burns based on pharmacokinetic/pharmacodynamic analysis (2016)
Silva, Vedilaine Aparecida Bueno da; Silva-Jr, Carlindo Vieira; Sanches-Giraud, Cristina; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vedilaine Aparecida Bueno da et al. Vancomycin dose adjustment in pediatric burns based on pharmacokinetic/pharmacodynamic analysis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2016
APA
Silva, V. A. B. da, Silva-Jr, C. V., Sanches-Giraud, C., Gomez, D. de S., & Santos, S. R. C. J. (2016). Vancomycin dose adjustment in pediatric burns based on pharmacokinetic/pharmacodynamic analysis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Silva VAB da, Silva-Jr CV, Sanches-Giraud C, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in pediatric burns based on pharmacokinetic/pharmacodynamic analysis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 14 res. FCF023.[citado 2024 nov. 17 ]
Vancouver
Silva VAB da, Silva-Jr CV, Sanches-Giraud C, Gomez D de S, Santos SRCJ. Vancomycin dose adjustment in pediatric burns based on pharmacokinetic/pharmacodynamic analysis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 14 res. FCF023.[citado 2024 nov. 17 ]
Trabalho de evento-resumo periodico
Empirical daily dose of vancomycin in septic critically ill patients based on PK/PD analysis (2016)
Souza, Vanessa Kasubeck de; Silva Junior, Carlindo Vieira da; Gomez, David de Souza; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: MEDICAMENTO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Vanessa Kasubeck de et al. Empirical daily dose of vancomycin in septic critically ill patients based on PK/PD analysis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2016
APA
Souza, V. K. de, Silva Junior, C. V. da, Gomez, D. de S., & Santos, S. R. C. J. (2016). Empirical daily dose of vancomycin in septic critically ill patients based on PK/PD analysis. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Souza VK de, Silva Junior CV da, Gomez D de S, Santos SRCJ. Empirical daily dose of vancomycin in septic critically ill patients based on PK/PD analysis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 45 res. FCF085.[citado 2024 nov. 17 ]
Vancouver
Souza VK de, Silva Junior CV da, Gomez D de S, Santos SRCJ. Empirical daily dose of vancomycin in septic critically ill patients based on PK/PD analysis. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 45 res. FCF085.[citado 2024 nov. 17 ]
Artigo de periodico
Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment (2015)
Gomez, David de Souza; Giraud, Cristina Sanches; Silva Junior, Carlindo Vieira da; Oliveira, Amanda Maria Ribas Rosa de; Silva Júnior, João Manoel da; Gemperli, Rolf; Santos, Silvia Regina Cavani Jorge
Source: Journal of Antibiotics. Unidades: FCF, FM
Subjects: FARMACOCINÉTICA, ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMEZ, David de Souza et al. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment. Journal of Antibiotics, v. 68, p. 143-147, 2015Tradução . . Disponível em: https://doi.org/10.1038/ja.2014.121. Acesso em: 17 nov. 2024.
APA
Gomez, D. de S., Giraud, C. S., Silva Junior, C. V. da, Oliveira, A. M. R. R. de, Silva Júnior, J. M. da, Gemperli, R., & Santos, S. R. C. J. (2015). Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment. Journal of Antibiotics, 68, 143-147. doi:10.1038/ja.2014.121
NLM
Gomez D de S, Giraud CS, Silva Junior CV da, Oliveira AMRR de, Silva Júnior JM da, Gemperli R, Santos SRCJ. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment [Internet]. Journal of Antibiotics. 2015 ; 68 143-147.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/ja.2014.121
Vancouver
Gomez D de S, Giraud CS, Silva Junior CV da, Oliveira AMRR de, Silva Júnior JM da, Gemperli R, Santos SRCJ. Imipenem in burn patients: pharmacokinetic profile and PK/PD target attainment [Internet]. Journal of Antibiotics. 2015 ; 68 143-147.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/ja.2014.121
Artigo de periodico
Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method (2015)
Santos, Silvia Regina Cavani Jorge ; Giraud, Cristina Sanches; Silva Junior, Carlindo Vieira da; Gomez, David de Souza
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTIBIÓTICOS, CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Silvia Regina Cavani Jorge et al. Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 2, p. 305-315, 2015Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502015000200007. Acesso em: 17 nov. 2024.
APA
Santos, S. R. C. J., Giraud, C. S., Silva Junior, C. V. da, & Gomez, D. de S. (2015). Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method. Brazilian Journal of Pharmaceutical Sciences, 51( 2), 305-315. doi:10.1590/s1984-82502015000200007
NLM
Santos SRCJ, Giraud CS, Silva Junior CV da, Gomez D de S. Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 2): 305-315.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/s1984-82502015000200007
Vancouver
Santos SRCJ, Giraud CS, Silva Junior CV da, Gomez D de S. Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 2): 305-315.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/s1984-82502015000200007
Trabalho de evento-resumo periodico
PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose (2014)
Guimarães, Wanderson Vidigal; Gomez, David de Souza; Silva Junior, Carlindo Vieira da; Giraud, Cristina Sanches; Santos, Silvia Regina Cavani Jorge
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: CONTROLE DE INFECÇÕES, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Wanderson Vidigal et al. PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 17 nov. 2024. , 2014
APA
Guimarães, W. V., Gomez, D. de S., Silva Junior, C. V. da, Giraud, C. S., & Santos, S. R. C. J. (2014). PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Guimarães WV, Gomez D de S, Silva Junior CV da, Giraud CS, Santos SRCJ. PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 33 res. FCF062.[citado 2024 nov. 17 ]
Vancouver
Guimarães WV, Gomez D de S, Silva Junior CV da, Giraud CS, Santos SRCJ. PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 33 res. FCF062.[citado 2024 nov. 17 ]
Trabalho de evento-resumo
PK/PD correlation for vancomycin effectiveness in burn children (2013)
Santos, Silvia Regina Cavani Jorge ; Sanches-Giraud, Cristina; Silva Junior, Carlindo Vieira da; Paiva, Barbara Oliveira de souza; Silva Júnior, João Manoel da; Campos, E. V; Levin, Anna Sara Shafferman; Gomez, David de Souza
Source: Book of Abstracts. Conference titles: European Burns Association Congress. Unidades: FCF, FM
Subjects: QUEIMADURAS, CRIANÇAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Silvia Regina Cavani Jorge et al. PK/PD correlation for vancomycin effectiveness in burn children. 2013, Anais.. Vienna: Vienna Medical Academy, 2013. . Acesso em: 17 nov. 2024.
APA
Santos, S. R. C. J., Sanches-Giraud, C., Silva Junior, C. V. da, Paiva, B. O. de souza, Silva Júnior, J. M. da, Campos, E. V., et al. (2013). PK/PD correlation for vancomycin effectiveness in burn children. In Book of Abstracts. Vienna: Vienna Medical Academy.
NLM
Santos SRCJ, Sanches-Giraud C, Silva Junior CV da, Paiva BO de souza, Silva Júnior JM da, Campos EV, Levin ASS, Gomez D de S. PK/PD correlation for vancomycin effectiveness in burn children. Book of Abstracts. 2013 ;[citado 2024 nov. 17 ]
Vancouver
Santos SRCJ, Sanches-Giraud C, Silva Junior CV da, Paiva BO de souza, Silva Júnior JM da, Campos EV, Levin ASS, Gomez D de S. PK/PD correlation for vancomycin effectiveness in burn children. Book of Abstracts. 2013 ;[citado 2024 nov. 17 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles